SciELO - Scientific Electronic Library Online

 
vol.12 número4Evaluación de la eficacia de VA-MENGOC-BC® en ratón Balb/c retados frente a los serogrupos A, B y C índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Vaccimonitor

versión impresa ISSN 1025-028Xversión On-line ISSN 1025-0298

Resumen

RUIZ, Nancy M; ALVAREZ, Giselle  y  NOA, Enrique. Procedures for obtaining the biological reagents for the DAVIH Ag P24 and DAVIH Ac P24 kits. Vaccimonitor [online]. 2003, vol.12, n.4, pp.16-23. ISSN 1025-028X.

AIDS epidemic is one of the most serious problems affecting humanity today. Since science, despite all the great efforts made by scientists throughout the world, has not been able to find an effective vaccine to cure this disease, the use of anti-retroviral drugs has given the most successful results in improving life quality of AIDS patients. Hence, the importance of having the means to carry out an early diagnosis of the infection, as well as monitoring its progression with the purpose of having an influence on it. The present research work describes the obtaining of biological components required for the production of two kits used in Cuba for all HIV-AIDS related studies. To achieve this, a protocol was made that included different stages in the purification and immobilization of several molecules. Monoclonal antibody anti p24, HIV-1 p24, and polyclonal human antibodies anti p24 were obtained, with an adequate level of purity and biological activity allowing its use as intermediate products in the above mentioned stages and as reagents comprised in the kits.

Palabras clave : purification; monoclonal antibodies; immobilization; p24; HIV-1; polyclonal human antibodies.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons